SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-064541
Filing Date
2021-03-02
Accepted
2021-03-02 07:15:51
Documents
3
Period of Report
2021-03-02
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d340605d8k.htm 8-K 18382
2 EX-99.1 d340605dex991.htm EX-99.1 14149
3 GRAPHIC g340605page004.jpg GRAPHIC 3366
  Complete submission text file 0001193125-21-064541.txt   38486
Mailing Address 300 TECHNOLOGY SQUARE 2ND FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 2ND FLOOR CAMBRIDGE MA 02139 857-285-5314
Kymera Therapeutics, Inc. (Filer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39460 | Film No.: 21701282
SIC: 2836 Biological Products, (No Diagnostic Substances)